NCT03902249

Brief Summary

This study aims to determine if intravenous Dexamethasone combined with a pudendal nerve block is able to prolong postoperative analgesia in children undergoing hypospadias repair.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for phase_4 postoperative-pain

Timeline
Completed

Started Jan 2017

Typical duration for phase_4 postoperative-pain

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 1, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 4, 2019

Completed
Last Updated

April 4, 2019

Status Verified

April 1, 2019

Enrollment Period

2 years

First QC Date

April 1, 2019

Last Update Submit

April 2, 2019

Conditions

Keywords

Intravenous DexamethasonePudendal nerve blockAnalgesiaPostoperative painChildrenHypospadias

Outcome Measures

Primary Outcomes (2)

  • The mean time to first rescue analgesic

    Time from the end of surgery to the first administration of rescue analgesic

    The first 24 hours after surgery

  • number of rescue analgesic consumption

    Total number of rescue analgesic consumption for each patient

    The first 24 hours after surgery

Secondary Outcomes (2)

  • pain scores (CHEOPS)

    Hour 0, Hour 1, Hour 2, Hour 3, Hour 4, Hour 8, Hour 12, Hour 24

  • Number of episodes of postoperative nausea and vomiting

    The first 24 hours after surgery

Study Arms (2)

Dexamethasone group

ACTIVE COMPARATOR

Patients who received 0.15mg/kg of Dexamethasone in 8ml of saline

Drug: Dexamethasone

Placebo group

PLACEBO COMPARATOR

Patients who received the same volume of saline as the study group (8ml)

Drug: Dexamethasone

Interventions

Dexamethasone groupPlacebo group

Eligibility Criteria

Age1 Year - 18 Years
Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • ASA physical status classification 1 or 2
  • Procedure: hypospadias repair
  • Eligible for a pudendal nerve block

You may not qualify if:

  • parents or patient refusal
  • nerve block failure
  • Peroperative complication.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Khalifa SB, Slimene AB, Blaiti H, Kaddour R, Hassen AF, Pardessus P, Brasher C, Dahmani S. The potentiating effect of intravenous dexamethasone upon preemptive pudendal block analgesia for hypospadias surgery in children managed with Snodgrass technique: a randomized controlled study : Dexamethasone for pain management in children. BMC Anesthesiol. 2024 Apr 16;24(1):145. doi: 10.1186/s12871-024-02536-3.

MeSH Terms

Conditions

Pain, PostoperativeHypospadiasAgnosia

Interventions

Dexamethasone

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsUrogenital AbnormalitiesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPenile DiseasesGenital Diseases, MaleGenital DiseasesMale Urogenital DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

PregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, Fluorinated

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

April 1, 2019

First Posted

April 4, 2019

Study Start

January 1, 2017

Primary Completion

December 31, 2018

Study Completion

December 31, 2018

Last Updated

April 4, 2019

Record last verified: 2019-04